Alzamend Historical Financial Ratios
| ALZN Stock | USD 0.68 0.01 1.45% |
Alzamend Neuro is presently reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate Alzamend Neuro financial condition quickly.
Alzamend |
About Alzamend Financial Ratios Analysis
Alzamend NeuroFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Alzamend Neuro investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Alzamend financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Alzamend Neuro history.
Alzamend Neuro Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Alzamend Neuro's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Alzamend Neuro current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.At this time, Alzamend Neuro's Average Payables is very stable compared to the past year. As of the 17th of March 2025, ROIC is likely to grow to 4.09, while PTB Ratio is likely to drop (1.75).
Alzamend Neuro fundamentals Correlations
Click cells to compare fundamentals
Alzamend Neuro Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alzamend Neuro fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 486.9 | 6.8 | 17.01 | (1.85) | (1.67) | (1.75) | |
| Book Value Per Share | 4.16 | 22.52 | 4.69 | (3.84) | (3.45) | (3.28) | |
| Free Cash Flow Yield | (0.002767) | (0.0741) | (0.17) | (1.75) | (2.01) | (1.91) | |
| Operating Cash Flow Per Share | (5.6) | (11.15) | (13.73) | (12.23) | (14.07) | (14.77) | |
| Pb Ratio | 486.9 | 6.8 | 17.01 | (1.85) | (1.67) | (1.75) | |
| Free Cash Flow Per Share | (5.6) | (11.33) | (13.73) | (12.45) | (14.32) | (15.04) | |
| Roic | (1.89) | (0.93) | (4.84) | 4.33 | 3.9 | 4.09 | |
| Net Income Per Share | (10.75) | (20.92) | (22.89) | (14.72) | (16.92) | (17.77) | |
| Cash Per Share | 3.99 | 23.72 | 7.91 | 0.56 | 0.5 | 0.48 | |
| Pocfratio | (361.39) | (13.72) | (5.8) | (0.58) | (0.52) | (0.55) | |
| Pfcf Ratio | (361.39) | (13.5) | (5.8) | (0.57) | (0.51) | (0.54) | |
| Roe | (2.59) | (0.93) | (4.89) | 3.83 | 4.41 | 4.19 | |
| Ev To Operating Cash Flow | (360.8) | (11.59) | (5.23) | (0.57) | (0.51) | (0.54) | |
| Pe Ratio | (188.35) | (7.31) | (3.48) | (0.48) | (0.43) | (0.46) | |
| Return On Tangible Assets | (1.79) | (0.85) | (2.52) | (15.75) | (18.11) | (17.21) | |
| Ev To Free Cash Flow | (360.8) | (11.41) | (5.23) | (0.56) | (0.51) | (0.53) | |
| Earnings Yield | (0.005309) | (0.14) | (0.29) | (2.07) | (2.38) | (2.26) | |
| Current Ratio | 3.24 | 12.37 | 2.03 | 0.14 | 0.16 | 0.15 | |
| Tangible Book Value Per Share | 4.16 | 22.52 | 4.69 | (3.84) | (3.45) | (3.28) | |
| Shareholders Equity Per Share | 4.16 | 22.52 | 4.69 | (3.84) | (3.45) | (3.28) | |
| Graham Net Net | 2.14 | 21.75 | 3.49 | (4.22) | (3.79) | (3.6) | |
| Interest Debt Per Share | 1.02 | 0.0785 | 0.0118 | 0.46 | 0.53 | 0.64 | |
| Price Earnings Ratio | (188.35) | (7.31) | (3.48) | (0.48) | (0.43) | (0.46) | |
| Price Book Value Ratio | 486.9 | 6.8 | 17.01 | (1.85) | (1.67) | (1.75) | |
| Price Earnings To Growth Ratio | (11.71) | (0.0773) | (0.37) | 0.0135 | 0.0156 | 0.0148 | |
| Price To Operating Cash Flows Ratio | (361.39) | (13.72) | (5.8) | (0.58) | (0.52) | (0.55) | |
| Price To Free Cash Flows Ratio | (361.39) | (13.5) | (5.8) | (0.57) | (0.51) | (0.54) | |
| Effective Tax Rate | 0.003157 | (0.0311) | (0.00344) | 0.009734 | 0.0112 | 0.0106 | |
| Company Equity Multiplier | 2.21 | 1.45 | 1.09 | 1.94 | (0.24) | (0.22) | |
| Return On Capital Employed | (2.46) | (0.92) | (4.88) | 3.83 | 4.41 | 4.19 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.